Portfolio de Inovação
Anticorpos para tratamento contra bactérias diarreiogênicas
Anticorpos para tratamento contra bactérias diarreiogênicas
Anticorpos Para Tratamento Contra Bactérias Diarreiogênicas
Problema
The excessive use of antibiotics has led to the emergence of resistant strains, necessitating the constant search for new combat strategies and antimicrobial compounds. In diarrheagenic infections, antibiotic treatment can, in some cases, worsen the patient's condition, leading to the development of hemolytic-uremic syndrome.
Solução
The solution proposes the use of immunoglobulin Y (IgY) produced in eggs from immunized chickens with a specific antigen for the treatment of intestinal infections caused by diarrheagenic bacteria. The technology has the potential to reduce antibiotic use, thereby decreasing the risk of bacterial resistance and promoting ethical animal use.
Estágio de desenvolvimento
O que buscamos?
Seeking partnerships with pharmaceutical and/or nutraceutical industries for co-development and/or licensing of the technology for production and commercialization. Samples can be provided for collaborative testing
Use a câmera do seu celular para escanear o QR Code:
Campus Fiocruz Maré - Av. Brasil, 4036 - Maré, Rio de Janeiro - RJ
portfolio@fiocruz.br
+55 (21) 3282-9080
